✦ LIBER ✦

Epidermal Plasminogen Activator Activity, tPA-dependent, Is a Marker of Disease Activity in Psoriasis.

✍ Scribed by Lotti, Torello; Bonan, Paolo; Panconesi, Emiliano

Book ID: 110682285
Publisher: Nature Publishing Group
Year: 1988
Tongue: English
Weight: 744 KB
Volume: 90
Category: Article
ISSN: 0022-202X
DOI: 10.1111/1523-1747.ep12462580

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue plasminogen activator (tPA) activ

Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes

✍ David Sahli; Jan W. Eriksson; Kurt Boman; Maria K. Svensson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 255 KB

The receptor for urokinase-type plasmino

The receptor for urokinase-type plasminogen activator is a marker of activation in T-lymphocytes

✍ Møller, B.; Nykjær, A.; Gliemann, J.; Petersen, C.Munck 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Epidermal phospholipase A2 activity is r

Epidermal phospholipase A2 activity is raised in the uninvolved skin of psoriasis

✍ S. FORSTER; E. ILDERTON; R. SUMMERLY; H.J. YARDLEY 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Is dysfunction of the tissue plasminogen

Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease?

✍ Sheue-Jane Hou; Feng-Chang Yen; Shih-Jen Tsai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Effects of biological response modifiers

Effects of biological response modifiers on plasminogen activator activity in epidermal cell culture

✍ JUDITH M. BROWN; D. A. CHAMBERS 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Soluble urokinase plasminogen activator

Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy

✍ Ove Andersen; Jesper Eugen-Olsen; Kristian Kofoed; Johan Iversen; Steen B. Hauga 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Circulating soluble urokinase plasminogen activator receptor (suPAR) reflects the immune and pro‐inflammatory status of the HIV‐infected patient. Highly active antiretroviral therapy (HAART) suppresses suPAR. Independent of the immune response to HAART, suPAR remains elevated in some HI